Abbott (ABT) Provides Details on Restructuring Plan for Solvay's Pharma Unit; Sees Q3 Charge of $430M
Go back to Abbott (ABT) Provides Details on Restructuring Plan for Solvay's Pharma Unit; Sees Q3 Charge of $430M| Abbott Laboratories (NYSE: ABT) | Delayed: 112.68 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $112.68 | 52 Week High | $46.38 | |||
| Open | $112.68 | 52 Week Low | $36.00 | |||
| Day High | $112.68 | P/E | 75.12 | |||
| Day Low | $112.68 | EPS | $1.50 | |||
| Volume | 1,291 | |||||
